- Home
- TRDA vs DSU Comparison
TRDA vs DSU Comparison
Compare TRDA & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- DSU
- Stock Information
- Founded
- TRDA 2016
- DSU 1998
- Country
- TRDA United States
- DSU United States
- Employees
- TRDA N/A
- DSU N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- DSU Finance Companies
- Sector
- TRDA Health Care
- DSU Finance
- Exchange
- TRDA Nasdaq
- DSU Nasdaq
- Market Cap
- TRDA 502.9M
- DSU 504.9M
- IPO Year
- TRDA 2021
- DSU N/A
- Fundamental
- Price
- TRDA $9.56
- DSU $10.49
- Analyst Decision
- TRDA Strong Buy
- DSU
- Analyst Count
- TRDA 3
- DSU 0
- Target Price
- TRDA $25.67
- DSU N/A
- AVG Volume (30 Days)
- TRDA 108.5K
- DSU 148.2K
- Earning Date
- TRDA 05-06-2025
- DSU 01-01-0001
- Dividend Yield
- TRDA N/A
- DSU 10.06%
- EPS Growth
- TRDA N/A
- DSU N/A
- EPS
- TRDA 1.68
- DSU N/A
- Revenue
- TRDA $210,782,000.00
- DSU N/A
- Revenue This Year
- TRDA N/A
- DSU N/A
- Revenue Next Year
- TRDA N/A
- DSU N/A
- P/E Ratio
- TRDA $5.76
- DSU N/A
- Revenue Growth
- TRDA 63.38
- DSU N/A
- 52 Week Low
- TRDA $9.51
- DSU $9.22
- 52 Week High
- TRDA $21.79
- DSU $11.40
- Technical
- Relative Strength Index (RSI)
- TRDA 30.19
- DSU 40.05
- Support Level
- TRDA $9.75
- DSU $10.45
- Resistance Level
- TRDA $10.87
- DSU $10.52
- Average True Range (ATR)
- TRDA 0.53
- DSU 0.07
- MACD
- TRDA -0.00
- DSU 0.00
- Stochastic Oscillator
- TRDA 2.70
- DSU 33.33
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.